Cohance Lifesciences Limited
Cohance Lifesciences Limited (COHANCE.NS) Stock Overview
Explore Cohance Lifesciences Limited’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
114.9B
P/E Ratio
38.20
EPS (TTM)
$5.06
ROE
0.09%
COHANCE.NS Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Cohance Lifesciences Limited (COHANCE.NS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 40.80, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $1020.84.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 38.20 and a market capitalization of 114.9B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.